Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03182933 · ClinicalTrials.gov registry record · Phase 4
Liposomal Bupivacaine Versus Standard Bupivacaine in the Adductor Canal for Total Knee Arthroplasty
A Phase 4 study, sponsored by University of Wisconsin, Madison.
- Terminated
- Registry status
- Phase 4
- Development phase
- 64
- Enrollment target
NCT03182933 is a Phase 4 study that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 64 participants.
The verdict
NCT03182933, a Phase 4 study, was terminated before completion, sponsored by University of Wisconsin, Madison.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 64 participants
- Enrollment target
Study Summary
Study will evaluate the effect of liposomal bupivacaine versus standard bupivacaine on physical therapy measures and pain scores as well as opiate consumption.
Interventions
- DRUG Peripheral Nerve Blockade
- BEHAVIORAL 10 meter walk test on post-operative day 1
- OTHER In person and over the phone questionnaire
- DEVICE Force transduction of quadriceps strength
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2017-05-30 |
| Est. Completion | 2018-07-16 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03182933
The ClinicalTrials.gov registry entry for NCT03182933 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Peripheral Nerve Blockade is the first listed.
NCT03182933 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03182933 about?
NCT03182933 is a clinical study titled "Liposomal Bupivacaine Versus Standard Bupivacaine in the Adductor Canal for Total Knee Arthroplasty". Study will evaluate the effect of liposomal bupivacaine versus standard bupivacaine on physical therapy measures and pain scores as well as opiate consumption.
What is the current status of trial NCT03182933?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 64 participants. The study started on 2017-05-30. Estimated completion is 2018-07-16.
What interventions are being tested in trial NCT03182933?
The interventions under investigation include: Peripheral Nerve Blockade (DRUG), 10 meter walk test on post-operative day 1 (BEHAVIORAL), In person and over the phone questionnaire (OTHER), Force transduction of quadriceps strength (DEVICE).
Who is sponsoring clinical trial NCT03182933?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.